PerkinElmer's Oxford Immunotec receives U.S. FDA approval for T-cell select to automate clinically superior tuberculosis detection

PerkinElmer’s (NYSE: PKI) Oxford Immunotec today announced the U.S. Food and Drug Administration (FDA) has approved the use of the T-Cell Select™ reagent kit for the automation of its T-SPOT®.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories.

Related Keywords

China ,United States ,South Korea ,Oxford Immunotec ,Oxford Immunotecoct ,Phill Keefe ,Perkinelmer Oxford Immunotec ,Instagram ,Linkedin ,Twitter ,Drug Administration ,Youtube ,Perkinelmer ,National Medical Products Administration ,Facebook ,Ministry Of Food ,From Oxford Immunotecoct ,T Cell Select ,Cell Select ,Drug Safety ,Cell ,T Cell ,Tuberculosis ,Utomation ,Flood ,Iagnostic ,Wood ,N Vitro ,Dvd ,